[go: up one dir, main page]

ES2083357T3 - Manganeso-superoxido-dismutasa humana (hmn-sod). - Google Patents

Manganeso-superoxido-dismutasa humana (hmn-sod).

Info

Publication number
ES2083357T3
ES2083357T3 ES88103754T ES88103754T ES2083357T3 ES 2083357 T3 ES2083357 T3 ES 2083357T3 ES 88103754 T ES88103754 T ES 88103754T ES 88103754 T ES88103754 T ES 88103754T ES 2083357 T3 ES2083357 T3 ES 2083357T3
Authority
ES
Spain
Prior art keywords
dismutase
superoxide
hmn
sod
human manganese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88103754T
Other languages
English (en)
Inventor
Konrad Dr Heckl
Walter Dr Spevak
Elinborg Dr Ostermann
Andreas Dr Zophel
Edeltraud Dr Krystek
Ingrid Dr Maurer-Fogy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19873708306 external-priority patent/DE3708306A1/de
Priority claimed from DE19873717695 external-priority patent/DE3717695A1/de
Priority claimed from DE19873722884 external-priority patent/DE3722884A1/de
Priority claimed from DE19873744038 external-priority patent/DE3744038A1/de
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Application granted granted Critical
Publication of ES2083357T3 publication Critical patent/ES2083357T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/07—Fusion polypeptide containing a localisation/targetting motif containing a mitochondrial localisation signal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)

Abstract

EL OBJETO DE LA PRESENTE INVENCIONES UN PROCEDIMIENTO DE INGENIERIA GENETICA PARA LA OBTENCION DE MANGANESO-SUPEROXIDO-DISMUTASA HUMANA (HMN-SOD), LAS SECUENCIAS DE ADN QUE CODIFICAN ESTA ENZIMA, LOS VECTORES QUE CONTIENEN ESTAS SECUENCIAS DE ADN Y LAS CELULAS HUESPED QUE PUEDEN EXPRESARLAS ASI COMO LA ENZIMA PROPIAMENTE DICHA. SE DESCRIBEN ADEMAS PROPUESTA PARA LA UTILIZACION DE ESTA ENZIMA.
ES88103754T 1987-03-14 1988-03-10 Manganeso-superoxido-dismutasa humana (hmn-sod). Expired - Lifetime ES2083357T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19873708306 DE3708306A1 (de) 1987-03-14 1987-03-14 Humane mangan-superoxiddismutase (hmn-sod)
DE19873717695 DE3717695A1 (de) 1987-05-26 1987-05-26 Humane mangan-superoxiddismutase (hmn-sod)
DE19873722884 DE3722884A1 (de) 1987-07-10 1987-07-10 Humane mangan-superoxiddismutase (hmn-sod)
DE19873744038 DE3744038A1 (de) 1987-12-24 1987-12-24 Humane mangan-superoxiddismutase (hmn-sod)

Publications (1)

Publication Number Publication Date
ES2083357T3 true ES2083357T3 (es) 1996-04-16

Family

ID=27433860

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88103754T Expired - Lifetime ES2083357T3 (es) 1987-03-14 1988-03-10 Manganeso-superoxido-dismutasa humana (hmn-sod).

Country Status (18)

Country Link
US (3) US5240847A (es)
EP (2) EP0282899B1 (es)
JP (1) JP2860100B2 (es)
KR (1) KR880011339A (es)
AT (1) ATE132902T1 (es)
AU (1) AU618526B2 (es)
CA (1) CA1341387C (es)
DE (1) DE3854872D1 (es)
DK (1) DK133388A (es)
ES (1) ES2083357T3 (es)
FI (1) FI881185L (es)
GR (1) GR3019091T3 (es)
HU (1) HU212920B (es)
IE (2) IE960190L (es)
IL (1) IL85701A0 (es)
MX (1) MX9203619A (es)
NO (1) NO176884C (es)
PT (1) PT86955B (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714362A (en) * 1983-04-29 1998-02-03 Yeda Research And Development Co. Ltd. Human superoxide dismutase cDNA
US6610520B1 (en) 1985-11-22 2003-08-26 Bio-Technology General Corp. Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby
US6326003B1 (en) 1986-10-14 2001-12-04 Chiron Corporation Manganese superoxide dismutase cloning and expression in microorganisms
DE3854872D1 (de) * 1987-03-14 1996-02-22 Boehringer Ingelheim Int Humane Mangan-Superoxiddismutase (hMn-SOD)
ATE130196T1 (de) * 1987-03-27 1995-12-15 Bio Technology General Corp Menschliches mangansuperoxiddismutase und behandlungsverfahren.
JP2500543B2 (ja) * 1991-05-24 1996-05-29 住友化学工業株式会社 キメラｐ４５０産生菌株
PT587055E (pt) * 1992-09-09 2002-05-31 Bio Technology General Corp Utilizacao de manganes superoxidodismutase (mn-sod) para a preparacao de medicamentos para o tratamento de doencas em pequenas dosagens
US5843641A (en) * 1993-02-26 1998-12-01 Massachusetts Institute Of Technology Methods for the daignosis, of familial amyotrophic lateral sclerosis
IL109112A0 (en) * 1993-03-24 1994-06-24 Boehringer Ingelheim Pharma Pharmaceutical compositions containing human manganese superoxide dismutase
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
US6887856B1 (en) * 1993-10-15 2005-05-03 University Of Pittsburgh Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy
US5994339A (en) * 1993-10-15 1999-11-30 University Of Alabama At Birmingham Research Foundation Oxidant scavengers
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
US5506133A (en) * 1994-04-11 1996-04-09 Human Genome Sciences, Inc. Superoxide dismutase-4
JP2517894B2 (ja) * 1994-08-12 1996-07-24 住友化学工業株式会社 フェレドキシン及びフェレドキシン還元酵素を同時に発現させるキメラｐ４５０産生菌株
AU3758695A (en) * 1994-09-20 1996-04-09 Duke University Oxidoreductase activity of manganic porphyrins
US5834248A (en) * 1995-02-10 1998-11-10 Millennium Pharmaceuticals Inc. Compositions and methods using rchd534, a gene uregulated by shear stress
US6359194B1 (en) 1995-02-10 2002-03-19 Millennium Pharmaceuticals, Inc. Compositions and methods for the treatment and diagnosis of cardiovascular disease
CA2247246A1 (en) 1996-02-16 1997-08-21 Millennium Pharmaceuticals, Inc. Compositions and methods for the treatment and diagnosis of cardiovascular disease
US6099823A (en) * 1996-02-16 2000-08-08 Millennium Pharmaceuticals, Inc. Compositions and methods for the treatment and diagnosis of cardiovascular disease
AU8671798A (en) * 1997-07-30 1999-02-22 Betagene, Inc. Methods and compositions relating to no-mediated cytotoxicity
US6171856B1 (en) 1997-07-30 2001-01-09 Board Of Regents, The University Of Texas System Methods and compositions relating to no-mediated cytotoxicity
AU737650B2 (en) 1997-11-03 2001-08-23 Duke University Substituted porphyrins
CA2321934C (en) * 1998-02-25 2012-02-21 Paul Q. Anziano Manganese superoxide dismutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms
US6737506B1 (en) * 1998-02-25 2004-05-18 Paul Anziano Manganese superoxide dismutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms
DE69928655T2 (de) 1998-04-24 2006-08-24 Duke University Substituierte porphyrine
US6190658B1 (en) 1998-05-08 2001-02-20 Webb-Waring Institute For Biomedical Research Genetically modified manganese superoxide dismutase for treating oxidative damage
US6221848B1 (en) 1998-05-11 2001-04-24 University Of Pittsburgh Protection of the esophagus from chemotherapeutic or irradiation damage by gene therapy
GB9824282D0 (en) * 1998-11-05 1998-12-30 Microbiological Research Agenc Delivery of superoxide dismutase to neuronal cells
DK1155019T3 (da) 1999-01-25 2006-04-18 Nat Jewish Med & Res Center Substituerede porphyriner og deres terapeutiske anvendelse
US6265172B1 (en) * 1999-02-08 2001-07-24 University Of Kentucky Diagnostic test and therapy for manganese superoxide dismutate (mNsod) associated diseases
FR2806911B1 (fr) * 2000-03-28 2003-01-10 Univ Rene Descartes Utilisation de mimetiques de la sod dans le traitement d'insuffisances hepatocellulaires
CN1322825A (zh) * 2000-05-09 2001-11-21 上海博德基因开发有限公司 一种新的多肽——超氧化物歧化酶11和编码这种多肽的多核苷酸
EP1392328B1 (en) 2001-01-19 2009-08-12 National Jewish Medical and Research Center Medicament for protection in radiotherapy
EP1439842A4 (en) 2001-06-01 2009-09-02 Nat Jewish Med & Res Center OXIDANT CAPTAIN FOR THE TREATMENT OF DIABETES OR FOR THE USE IN THE TRANSPLANTATION OR INDUCTION OF IMMUNOTOLERANE
AU2002345699A1 (en) * 2001-06-13 2002-12-23 Webb-Waring Institute For Biomedical Research A diagnostic and prognostic method for evaluating ocular inflammation and oxidative stress and the treatment of the same
EP1513537A4 (en) 2002-06-07 2006-09-06 Univ Duke Substituted porphyrins
US8258105B2 (en) * 2003-10-07 2012-09-04 Isis Pharmaceuticals, Inc. Antisense oligonucleotides optimized for kidney targeting
US20050191653A1 (en) * 2003-11-03 2005-09-01 Freier Susan M. Modulation of SGLT2 expression
WO2006017559A1 (en) * 2004-08-02 2006-02-16 University Of Iowa Research Foundation Methods of inhibiting manganese-containing superoxide dismutase 2 (mnsod)
US9546312B2 (en) * 2007-08-31 2017-01-17 Hayes & Associates Endotherm systems and methods utilizing carbohydrate in non-oxidizing environment
US11382895B2 (en) 2008-05-23 2022-07-12 National Jewish Health Methods for treating injury associated with exposure to an alkylating species

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE813485A (fr) * 1973-04-16 1974-10-09 Superoxyde dismutases et leur application comme inhibiteurs d'oxydation
FR2225443B1 (es) * 1973-04-16 1976-11-12 Anvar
US4029819A (en) * 1973-04-16 1977-06-14 Etablissement Public Det: Agence Nationale De Valorisation De La Recherche Anver Superoxide dismutase and its application as an oxidation inhibitor
FR2240277B2 (es) * 1973-08-10 1976-12-17 Anvar
JPS5816685A (ja) * 1981-07-22 1983-01-31 Takeda Chem Ind Ltd 固定化酵素，その製造法および製剤
US5196335A (en) * 1983-04-29 1993-03-23 Yeda Research And Development Co., Ltd. Human superoxide dismutase cDNA
DE3486493T2 (de) * 1983-10-03 2003-05-22 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Klonieren von Superoxiddismutase und Expression in Mikroorganismen
US5066591A (en) * 1983-10-03 1991-11-19 Chiron Corporation Polypeptides of human copper/zinc superoxide dimutase
US4751180A (en) * 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
DK402785D0 (da) * 1985-09-03 1985-09-03 Syn Tek Ab Fremgangsmaade til fremstilling af et enzym
IE59498B1 (en) * 1985-11-22 1994-03-09 Bio Technology General Corp Human manganese superoxide dismutase analog, plasmid for its expression and method of recovering it in enzymatically active form
US5270195A (en) * 1985-11-22 1993-12-14 Bio-Technology General Corp. Plasmids for expression and method of producing a human manganese superoxide dimutase analog
US5246847A (en) * 1985-11-22 1993-09-21 Bio-Technology General Corp. Polypeptide analogs of human manganese superoxide dismutase and compositions and complexes thereof
DE3854872D1 (de) * 1987-03-14 1996-02-22 Boehringer Ingelheim Int Humane Mangan-Superoxiddismutase (hMn-SOD)
US5260204A (en) * 1987-03-14 1993-11-09 Boehringer Ingelheim International Gmbh Human manganese superoxide dismutase (hMn-SOD)
ATE130196T1 (de) * 1987-03-27 1995-12-15 Bio Technology General Corp Menschliches mangansuperoxiddismutase und behandlungsverfahren.
US5223538A (en) * 1987-03-31 1993-06-29 Duke University Superoxide dismutase mimic
NZ225760A (en) * 1987-08-14 1991-02-26 Bio Technology General Corp Expression plasmids containing the deo promoter and bacterial hosts containing these plasmids
JPH0283398A (ja) * 1988-09-21 1990-03-23 Ube Ind Ltd 合成ペプチド、それを用いたヒトＭｎ−スーパーオキシドジスムターゼの測定キットおよび測定法
EP0462836A3 (en) * 1990-06-20 1992-08-26 Mitsui Toatsu Chemicals, Inc. Recombinant vector plasmid capable of expressing human manganese superoxide dismutase, and process of producing this enzyme

Also Published As

Publication number Publication date
AU1302788A (en) 1988-09-15
JP2860100B2 (ja) 1999-02-24
NO881089D0 (no) 1988-03-11
NO176884C (no) 1995-06-14
PT86955B (pt) 1992-06-30
IE880717L (en) 1988-09-14
DE3854872D1 (de) 1996-02-22
IE71940B1 (en) 1997-03-12
US5436162A (en) 1995-07-25
FI881185L (fi) 1988-09-15
NO176884B (no) 1995-03-06
AU618526B2 (en) 1992-01-02
NO881089L (no) 1988-09-15
US5240847A (en) 1993-08-31
EP0282899A2 (de) 1988-09-21
MX9203619A (es) 1992-09-01
IL85701A0 (en) 1988-08-31
DK133388D0 (da) 1988-03-11
US5589371A (en) 1996-12-31
EP0676472A1 (de) 1995-10-11
PT86955A (pt) 1988-04-01
IE960190L (en) 1988-09-14
KR880011339A (ko) 1988-10-27
ATE132902T1 (de) 1996-01-15
CA1341387C (en) 2002-09-03
FI881185A0 (fi) 1988-03-14
HU212920B (en) 1996-12-30
DK133388A (da) 1988-09-15
HUT46739A (en) 1988-11-28
GR3019091T3 (en) 1996-05-31
EP0282899B1 (de) 1996-01-10
JPS6463383A (en) 1989-03-09
EP0282899A3 (en) 1989-11-15

Similar Documents

Publication Publication Date Title
ES2083357T3 (es) Manganeso-superoxido-dismutasa humana (hmn-sod).
DK81993A (da) Fremgangsmaade til fremstilling af 2-thioalkoxy-6-alkoxy-7-iod-7-deazapuriner
ES552095A0 (es) Un procedimiento para aislar un gen de preprorrelaxina -h2 humana o un equivalente o subunidad del mismo
ES2058094T3 (es) Interferon-gamma de caballo.
ES544126A0 (es) Procedimiento para la obtencion de secuencias de dna
ES517234A0 (es) Procedimiento para la obtencion de trimeros mixtos de isocianatos organicos.
ES2036192T3 (es) Derivados del acido (met)-acrilico, que contienen grupos uretano, de triciclo (5.2.1.0.2.6) decano.
DK288183D0 (da) Fremgangsmade til fremstilling af et oligonucleotidt terapeutisk middel
ES2061587T3 (es) Compuestos aromaticos y heteroaromaticos alfa,alfa-disustituidos como mejoradores de la cognicion.
ES2055587T3 (es) El uso de agonistas selectivos de gaba-b como agentes antitusivos.
ES2114876T3 (es) Hidroxialquilacion de fenoles o tiofenoles con carbonatos organicos ciclicos utilizando catalizadores de triorganofosfino.
ES8603579A1 (es) Un procedimiento para producir un vector de transferencia de adn.
ES2026669T3 (es) Procedimiento para la preparacion y el uso terapeutico de los beta-d-fenil tioxilosidos.
ES8707243A1 (es) Un procedimiento para preparar derivados de tienopiridona
ES2104596T3 (es) Nuevos polipeptidos, secuencias de adn que permiten su expresion, metodo de preparacion, y utilizacion.
ES2059436T3 (es) Proteina de la membrana exterior f de pseudomonas aeruginosa.
ES2064328T3 (es) Indolilpropanoles, procedimiento para su fabricacion y su uso, asi como preparaciones que contienen los compuestos.
ES2123641T3 (es) Secuencias de acidos nucleicos que codifican o que son complementarias a secuencias de acidos nucleicos que codifican para el receptor de la interleucina 9.
BR8907503A (pt) Hidrofluoracao de alcanos halogenados catalisada com tax5
ES2059444T3 (es) Procedimiento para la obtencion de acroleinas alfa,beta-substituidas.
JPS5628300A (en) Method of retanning leather tanned with mineral with aromatic sulfonic acid
CO4230141A1 (es) Acc-sintasa de crucifera y sus usos
ES555678A0 (es) Procedimiento para la tintura del cuero de pieles lanares o con pelo
ES2031274T3 (es) Procedimiento de preparacion de diaminas aromaticas con un grupo polidiorganosiloxano.
ES2166757T3 (es) Secuencias de adn del virus de epstein-barr que codifican un antigeno de la capsida del virus de interes diagnostico, clones de expresion obtenidos por la reaccion en cadena de la polimerasa y el uso de este antigeno recombinante en ensayos de diagnostico.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 282899

Country of ref document: ES